US46185L1035 - Common Stock
INVITAE CORP
NYSE:NVTA (2/5/2024, 6:40:05 PM)
0.0891
-0.3 (-77.12%)
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. The company is headquartered in San Francisco, California and currently employs 1,700 full-time employees. The company went IPO on 2015-02-12. The firm is engaged in delivering genetic testing services, digital health solutions, and health data services that support a lifetime of patient care and improved outcomes. The company offers genetic testing across multiple clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases and pharmacogenomics. The company applies proprietary design, process automation, robotics and bioinformatics software solutions to expand the use and impact of genetic information in sample processing and complex variant interpretation, allowing medical interpretation at scale. The firm also utilizes digital health solutions to improve ease-of-use and to deliver actionable information about risk, prevention, treatment, and monitoring. The firm has served over 3.6 million patients, and over 2.2 million of those patients have made their information available for data sharing.
INVITAE CORP
1400 16Th Street
San Francisco CALIFORNIA 94103
P: 14153747782
CEO: Sean E. George
Employees: 1700
Website: https://www.invitae.com
More on Invitae Invitae's High-Stakes Financial Maneuvering: Dilution Might Not Be That Bad Stocks To Watch: Energy Market Drama And Financial Earnings Headline
Invitae Corp., a genetic-testing company with backers including Softbank Group Corp. and Cathie Wood’s Ark Investment Management, has filed for bankruptcy as the DNA testing industry struggles to regain investor interest following a pandemic-era boom.
The New York Stock Exchange has announced that it will begin the process of delisting NVTA stock based on its "abnormally low" price.
Agrify stock is rising higher on Tuesday as investors in AGFY celebrate a new milestone for the company with a successful installation.
NVTA stock tumbled yesterday amid a report that the firm could declare bankruptcy soon. The shares were halted for news pending.
Genetics company Invitae (NVTA) has dropped 70% after reports suggest it has hired restructuring advisers and may be preparing for bankruptcy.
Here you can normally see the latest stock twits on NVTA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: